Kubacka, D.; Kozarski, M.; Baranowski, M.R.; Wojcik, R.; Panecka-Hofman, J.; Strzelecka, D.; Basquin, J.; Jemielity, J.; Kowalska, J.
Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism. Pharmaceuticals 2022, 15, 554.
https://doi.org/10.3390/ph15050554
AMA Style
Kubacka D, Kozarski M, Baranowski MR, Wojcik R, Panecka-Hofman J, Strzelecka D, Basquin J, Jemielity J, Kowalska J.
Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism. Pharmaceuticals. 2022; 15(5):554.
https://doi.org/10.3390/ph15050554
Chicago/Turabian Style
Kubacka, Dorota, Mateusz Kozarski, Marek R. Baranowski, Radoslaw Wojcik, Joanna Panecka-Hofman, Dominika Strzelecka, Jerome Basquin, Jacek Jemielity, and Joanna Kowalska.
2022. "Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism" Pharmaceuticals 15, no. 5: 554.
https://doi.org/10.3390/ph15050554
APA Style
Kubacka, D., Kozarski, M., Baranowski, M. R., Wojcik, R., Panecka-Hofman, J., Strzelecka, D., Basquin, J., Jemielity, J., & Kowalska, J.
(2022). Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism. Pharmaceuticals, 15(5), 554.
https://doi.org/10.3390/ph15050554